Aryl-substituted symmetrical and unsymmetrical benzothiadiazoles

Prabhat Gautam, Ramesh Maragani and Rajneesh Misra*
Department of Chemistry, Indian Institute of Technology Indore, Indore 452 017, India. E-mail: rajneeshmisra@iiti.ac.in; Fax: +91 7312361482; Tel: +91 7312438710

Received 28th November 2014 , Accepted 3rd February 2015

First published on 6th February 2015


Abstract

A set of benzothiadiazoles (BTD) of the type D–π–A–π–D and D1–π–A–π–D2 were designed and synthesized by the Pd-catalyzed Sonogashira cross-coupling reaction. Their photophysical and electrochemical properties were studied. The substitution of anthracene on BTD improves its thermal stability, and lowers the HOMO–LUMO gap, which results in a red shift of the electronic absorption. The experimental optical gap values show good agreement with the calculated HOMO–LUMO gap.


Introduction

The design and synthesis of donor–acceptor (D–A) molecular systems are of significant interest, because of their application in organic light emitting diodes (OLEDs), organic photovoltaic devices (OPVs), organic thin film transistors (OTFTs), and non-linear optics (NLO).1,2 The photonic properties of donor–acceptor molecular systems can be tuned by varying the strength of the donor as well as the acceptor.3,4 Benzothiadiazole is a strong acceptor and has been widely studied in OPVs and NLO.5,6

Our group is interested in the design and synthesis of donor–acceptor molecular systems with low HOMO–LUMO gap.7 Recently we have reported symmetrical and unsymmetrical BTD based molecular systems of the type D–π–A–π–D, D–π–A–D, D–π–A–π–A–π–D and D–A–A–A–D.8 We were interested to see the effect of different aryl groups on the HOMO–LUMO gap and thermal stability of a BTD based donor–acceptor molecular system. In this contribution we wish to report BTD based molecular systems of the type D–π–A–π–D and D1–π–A–π–D2 with a planar anthracene unit, and non-planar triphenylamine and triarylborane units (Chart 1).


image file: c4ra15424j-c1.tif
Chart 1 Aryl-substituted benzothiadiazoles.

Result and discussion

Synthesis

The synthetic route for aryl substituted benzothiadiazoles 2, 3, 8 and 9 are shown in Schemes 1, 2 and S1. The dibromobenzothiadiazole 1, was synthesized by the bromination reaction of benzothiadiazole.9 The aryl substituted symmetrical benzothiadiazoles 2 and 3 were synthesised by the Pd-catalyzed Sonogashira cross-coupling reaction of dibromobenzothiadiazole 1, with 9-ethynylanthracene (4) and (4-ethynylphenyl)dimesitylborane (5) in 84% and 62% yield respectively.10
image file: c4ra15424j-s1.tif
Scheme 1 Synthesis of BTDs 2 and 3.

image file: c4ra15424j-s2.tif
Scheme 2 Synthesis of BTDs 8 and 9.

The Sonogashira cross-coupling reaction of 1 equivalent of dibromobenzothiadiazole 1, with 1.2 equivalent of (4-ethynylphenyl)diphenylamine resulted BTD 6 (chart) and intermediate 7 in 30% and 52% respectively (Scheme S1).1d,11 The aryl substituted unsymmetrical benzothiadiazoles 8 and 9 were synthesised by the Pd-catalyzed Sonogashira cross-coupling reactions of intermediate 7, with 9-ethynylanthracene (4) and 4-ethynylphenyl-dimesitylborane (5) in 74% and 72% yield respectively (Scheme 2).12 Benzothiadiazoles 2, 3, 6, 8 and 9 were well characterized by 1H, 13C NMR, and HRMS techniques.

Thermal stability

The thermal stability of donor–acceptor organic chromophore are significant for their practical applications. The thermal stability of BTDs 2, 3, 6, 8 and 9 were determined by thermogravimetric analysis (TGA) at a heating rate of 10 °C min−1, under nitrogen atmosphere (Fig. 1). The decomposition temperatures (Td) values for 5% weight loss of the BTDs are listed in Table 1. The trend in thermal stability follows the order 2 > 8 > 6 > 9 > 3. This indicates incorporation of planar anthracene in BTDs 2 and 8 improves the thermal stability. On the other hand incorporation of phenyl-dimesitylborane results in lower thermal stability.
image file: c4ra15424j-f1.tif
Fig. 1 TGA plots of benzothiadiazoles 2, 3, 6, 8 and 9 at a heating rate of 10 °C min−1, under nitrogen atmosphere.
Table 1 Photophysical and electrochemical data of BTDs 2, 3, 6, 8 and 9
BTD Photophysical dataa Electrochemical datae Tdg (°C)
λabs (nm) ε (M−1 cm−1) λem (nm) Φf Stoke's shift (cm−1) Optical gapd (eV) Eox (V) Ered (V)
a Absorbance measured in dichloromethane at 1 × 10−5 M concentration; λabs: absorption wavelength; λem: emission wavelength; ε: extinction coefficient.b Calculated using quinine sulfate in 1 M H2SO4, Φf = 0.55, as standard.c Fluorescence quantum yield relative to rhodamine B in ethanol (0.65).d Determined from onset wavelength of the UV-vis absorption.e Recorded by cyclic voltammetry, in 0.1 M solution of TBAPF6 in DCM at 100 mV s−1 scan rate versus SCE electrode.f For the irreversible redox process, the peak potential is quoted.g Decomposition temperatures for 5% weight loss under N2 atmosphere at heating rate of 10 °C min−1.
2 508 31[thin space (1/6-em)]344 613 0.32c 3372 2.14 −1.21 456
3 419 58[thin space (1/6-em)]500 502 0.38c 3946 2.64 −1.29 162
6 484 38[thin space (1/6-em)]000 663 0.19b 5578 2.24 0.99f −1.28 379
8 494 32[thin space (1/6-em)]885 672 0.22b 5362 2.20 0.89f −1.26 405
9 470 54[thin space (1/6-em)]316 692 0.27b 6826 2.28 0.88f −1.31 184


Theoretical calculations

In order to explore the electronic structure of the aryl substituted symmetrical and unsymmetrical BTDs, DFT (density functional theory) calculations were performed at the B3LYP/6-31G** level.13 The contours of the HOMO and LUMO of BTDs 2, 3, 6, 8 and 9 are shown in Fig. 2.
image file: c4ra15424j-f2.tif
Fig. 2 HOMO and LUMO frontier orbitals of BTDs 2, 3, 6, 8 and 9 at the B3LYP/6-31G** level for C, N, S and H.

The computational results indicate the following: (a) in BTDs 2, 6 and 8 the HOMO orbitals are localized over anthracene, triphenylamine and benzo of the BTD unit, whereas the LUMO is delocalized over the benzothiadiazole. (b) In case of BTDs 3 and 8 the HOMO is delocalized over the triphenylamine, phenyl ring of phenyl-dimesitylborane and benzo of the BTD unit whereas the LUMO over the BTD and phenyl of the phenyldimesitylborane unit. (c) The HOMO–LUMO gap in BTDs 2, 3, 6, 8 and 9 are 2.15 eV, 2.70 eV, 2.32 eV, 2.22 eV and 2.35 eV respectively. The trend observed in the HOMO–LUMO gap exhibits the order 3 > 9 > 6 > 8 > 2. These results indicate that the incorporation of anthracene and triphenylamine unit lowers the HOMO–LUMO gap whereas phenyl-dimesitylborane unit increases the HOMO–LUMO gap (Fig. 3).


image file: c4ra15424j-f3.tif
Fig. 3 Energy diagram of the frontier orbitals of benzothiadiazole 2, 3, 6, 8 and 9 estimated by DFT calculations.

Photophysical properties

The electronic absorption and emission spectra of benzothiadiazoles 2, 3, 6, 8 and 9 were recorded in dichloromethane at room temperature (Fig. 4), and the data are compiled in Table 1. Benzothiadiazoles 2, 3, 6, 8 and 9 exhibit a high energy absorption band between 300–350 nm, corresponding to π → π* transition.14 The charge transfer (CT) band in BTD 2, 3, 6, 7 and 8 were observed at ∼505 nm, ∼419 nm, ∼484 nm, ∼492 nm and ∼470 nm respectively.14,15 The CT band exhibits larger red shift in anthracene substituted BTDs 2 and 8. The DFT results indicate that substitution of the anthracene units on the BTD core results in completely planar conformation of BTD 2. This results in strong electronic communication between the donor anthracene and the acceptor BTD core. However, the substitution of electron deficient phenyl-dimesitylborane unit on the acceptor BTD results is relatively weak electronic communication, which results in blue shift of the absorption spectrum. The trend observed in the optical gap exhibits the order 3 > 9 > 6 > 8 > 2. The experimental optical gap values show good agreement with the calculated HOMO–LUMO gap.
image file: c4ra15424j-f4.tif
Fig. 4 Normalized electronic absorption and emission spectra of BTDs 2, 3, 6, 8 and 9 in dichloromethane.

The fluorescence spectra of BTD 2, 3, 6, 8 and 9 displays a single emission peak at 613 nm, 502 nm, 663 nm, 672 nm and 692 nm respectively. The BTDs 6, 8 and 9 bearing triphenylamine as one of the donor unit exhibit large Stoke's shift compared to BTDs 2 and 3. The effect of variation of π-conjugation through different aryl groups is also reflected from the colored solution (Fig. 5).


image file: c4ra15424j-f5.tif
Fig. 5 Benzothiadiazoles 2, 3, 6, 8 and 9 illuminated under white light (daylight lamp).

Electrochemical properties

The electrochemical properties of compounds 2, 3, 6, 8 and 9 were explored by the cyclic voltammetric analysis in dichloromethane (DCM) solution using tetrabutylammonium hexafluorophosphate (Bu4NPF6) as supporting electrolyte. The cyclic voltammograms are presented in Fig. 6, S17 and S18, and the data are listed in Table 1. The aryl-substituted benzothiadiazoles 2, 3, 6, 8 and 9 exhibit one reversible reduction wave corresponding to the BTD acceptor moiety.16 The reduction potentials of anthracene substituted BTDs 2 and 8 are −1.21 V and −1.26 V respectively whereas, the reduction potentials of phenyl-dimesitylborane substituted BTDs 3 and 9 are −1.29 V and −1.31 V respectively. The reduction potential data shows that the ease of reduction follows the order 2 > 8 > 6 > 3 > 9.17 The irreversible oxidation peaks corresponding to the oxidation of the triphenylamine unit for BTDs 6, 8 and 9 were observed in the region 0.88–0.99 V.18
image file: c4ra15424j-f6.tif
Fig. 6 Cyclic voltammograms of BTDs 2, 3, 8 and 9 at 0.01 M concentration in 0.1 M TBAPF6 in dichloromethane recorded at a scan rate of 100 mV s−1.

Conclusion

In summary symmetrical and unsymmetrical donor–acceptor benzothiadiazole (BTD) were synthesized by the Pd-catalyzed Sonogashira cross-coupling reaction. Their photophysical, computational and thermal properties reveal that the substitution of anthracene unit results in red shifted absorption band, lower optical gap and improved thermal stability. The results obtained in this study will be useful for the design and synthesis low HOMO–LUMO gap molecular motifs for organic photovoltaics. The study towards the optoelectronic applications of anthracene based BTDs are currently ongoing in our laboratory.

Experimental section

Experimental details

Chemicals were used as received unless otherwise indicated. All the oxygen or moisture sensitive reactions were carried out under argon/nitrogen atmosphere. 1H NMR spectra were recorded using a 400 MHz spectrometer. Chemical shifts are reported in delta (δ) units, expressed in parts per million (ppm) downfield from tetramethylsilane using residual protonated solvent as an internal standard {CDCl3, 7.26 ppm}. 13C NMR spectra were recorded using a 100 MHz spectrometer. Chemical shifts are reported in delta (δ) units, expressed in parts per million (ppm) downfield from tetramethylsilane using the solvent as internal standard {CDCl3, 77.0 ppm}. The 1H NMR splitting patterns have been described as “s, singlet; d, doublet; t, triplet and m, multiplet”. UV-visible absorption spectra of all compounds were recorded in DCM. Emission spectra were taken in a fluoromax-4p fluorimeter from HoribaYovin (model: FM-100). The excitation and emission slits were 2/2 nm for the emission measurements. The density functional theory (DFT) calculation were carried out at the B3LYP/6-31G** level for C, N, S, H in the Gaussian 09 program. HRMS was recorded on TOF-Q mass spectrometer. Cyclic voltammograms and differential pulse voltammograms were recorded on electrochemical analyzer using glassy carbon as working electrode, Pt wire as the counter electrode, and saturated calomel electrode (SCE) as the reference electrode. The scan rate was 100 mV s−1 for CV. A solution of tetrabutylammonium hexafluorophosphate (TBAPF6) in DCM (0.1 M) was employed as the supporting electrolyte. DCM was freshly distilled from CaH2 prior to use. All potentials were experimentally referenced against the saturated calomel electrode couple. Under our conditions, the Fc/Fc+ couple exhibited E0 = 0.38 V versus SCE. Thermogravimetric analyses were performed on the Mettler Toledo thermal analysis system.

Preparation of benzothiazole 2

To a stirred solution of the 9-ethynylanthracene (2.5 mmol), and dibromo-BTD 1 (1 mmol) in THF, and TEA (1[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v) were added [PdCl2(PPh3)2] (20 mg, 0.028 mmol) and CuI (4 mg, 0.02 mmol) under an argon flow at room temperature. The reaction mixture was stirred for 12 h at 70 °C, and then cooled to room temperature. The solvent was then evaporated under reduced pressure, and the mixture was purified by SiO2 chromatography with DCM/hexane (2[thin space (1/6-em)]:[thin space (1/6-em)]3, v/v) to obtain 2 as deep red solid (450 mg, yield: 84%). 1H NMR (400 MHz, CDCl3, δ in ppm): 8.95–8.93 (m, 4H), 8.53 (s, 2H), 8.08–8.06 (m, 6H), 7.74–7.70 (m, 4H), 7.60–7.56 (m, 4H); 13C NMR (100 MHz, CDCl3, δ in ppm): precipitate formation at higher concentration resulted poor spectrum; HRMS (ESI-TOF) m/z calcd for C38H20N2S + H: 537.1420 [M + H]+, found 537.1409 [M + H]+.

Preparation of benzothiazole 3

To a stirred solution of the 4-ethynylphenyl-dimesitylborane (2.5 mmol), and dibromo-BTD 1 (1 mmol) in THF, and TEA (1[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v) were added [PdCl2(PPh3)2] (10 mg, 0.014 mmol) and CuI (2 mg, 0.01 mmol) under an argon flow at room temperature. The reaction mixture was stirred for 24 h at 70 °C, and then cooled to room temperature. The solvent was then evaporated under reduced pressure, and the mixture was purified by SiO2 chromatography with DCM/hexane (1[thin space (1/6-em)]:[thin space (1/6-em)]3, v/v), followed by recrystallization in DCM/hexane (1[thin space (1/6-em)]:[thin space (1/6-em)]3) to obtain 3 as yellow solid (507 mg, yield: 62%). 1H NMR (400 MHz, CDCl3, δ in ppm): 7.81 (s, 2H), 7.64–7.61 (m, 4H), 7.55–7.53 (m, 4H), 6.84 (s, 8H), 2.32 (s, 12H), 2.01 (s, 24H); 13C NMR (100 MHz, CDCl3, δ in ppm): 154.3, 151.0, 140.9, 139.0, 136.0, 132.6, 131.4, 128.3, 126.9, 125.5, 117.2, 97.8, 87.0, 23.4, 21.2; HRMS (ESI-TOF) m/z calcd for C58H54B2N2S + Na: 855.4104 [M + Na]+, found 855.4063 [M + Na]+.

Preparation of benzothiadiazole 8

To a stirred solution of 9-ethynylanthracene (1.2 mmol), 7 (1 mmol) in THF, and TEA (1[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v) were added [PdCl2(PPh3)2] (10 mg, 0.014 mmol) and CuI (2 mg, 0.01 mmol) under an argon flow at room temperature. The reaction mixture was stirred for 18 h at 70 °C, and then cooled to room temperature. The solvent was then evaporated under reduced pressure, and the mixture was purified by SiO2 chromatography with DCM/hexane (2[thin space (1/6-em)]:[thin space (1/6-em)]2, v/v), to obtain 8 as red solid (447 mg, yield: 74%). 1H NMR (400 MHz, CDCl3, δ in ppm): 8.91–8.88 (m, 2H), 8.51 (s, 1H), 8.07–8.05 (m, 2H), 7.99 (d, J = 7.5, 1H), 7.84 (d, J = 7.2, 1H), 7.71–7.67 (m, 3H), 7.58–7.52 (m, 4H), 7.33–7.28 (m, 4H), 7.16–7.03 (m, 7H); 13C NMR (100 MHz, CDCl3, δ in ppm): 154.7, 154.5, 148.7, 147.0, 135.0, 133.0, 132.97, 132.0, 131.8, 131.2, 121.8, 117.5, 117.0, 116.6, 115.0, 98.5, 97.0; HRMS (ESI-TOF) m/z calcd for C42H25N3S + Na: 626.1661 [M + Na]+, found 626.1673 [M + Na]+.

Preparation of benzothiadiazole 9

To a stirred solution of the 4-ethynylphenyl-dimesitylborane (1.5 mmol), 7 (1 mmol) in THF, and TEA (1[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v) were added [PdCl2(PPh3)2] (10 mg, 0.014 mmol) and CuI (2 mg, 0.01 mmol) under an argon flow at room temperature. The reaction mixture was stirred for 20 h at 70 °C, and then cooled to room temperature. The solvent was then evaporated under reduced pressure, and the mixture was purified by SiO2 chromatography with DCM/hexane (2[thin space (1/6-em)]:[thin space (1/6-em)]2, v/v), to obtain 9 as orange-red solid (540 mg, yield: 72%); 1H NMR (400 MHz, CDCl3, δ in ppm): 7.79 (d, 1H, J = 7.3 Hz), 7.75 (d, 1H, J = 7.3 Hz), 7.63 (d, 2H, J = 8.3 Hz), 7.54–7.49 (m, 4H), 7.32–7.28 (m, 4H), 7.15–7.01 (m, 8H), 6.84 (s, 4H), 2.32 (s, 6H), 2.01 (s, 12H); 13C NMR (100 MHz, CDCl3, δ in ppm): 154.3, 148.7, 146.9, 140.8, 138.9, 136.0, 133.0, 132.7, 131.9, 129.4, 128.2, 125.7, 125.3, 123.9, 121.7, 117.9, 116.3, 116.2, 114.8, 114.76, 98.6, 97.4, 95.1, 87.2, 84.8, 23.4, 21.4; HRMS (ESI-TOF) m/z calcd for C52H42BN3S + H: 752.3274 [M + H]+, found 752.3279 [M + H]+.

Acknowledgements

RM thanks CSIR, and DST, New Delhi for financial support.

Notes and references

  1. (a) Y. Lin, Y. Li and X. Zhan, Chem. Soc. Rev., 2012, 41, 4245–4272 RSC; (b) Y. Li, Q. Guo, Z. Li, J. Pei and W. Tian, Energy Environ. Sci., 2010, 3, 1427–1436 RSC; (c) B. A. D. Neto, A. A. M. Lapis, E. N. Júnior, S. da and J. Dupont, Eur. J. Org. Chem., 2013, 228–255 CrossRef CAS; (d) S. Kato, T. Matsumoto, T. Ishi-i, T. Thiemann, M. Shigeiwa, H. Gorohmaru, S. Maeda, Y. Yamashitad and S. Mataka, Chem. Commun., 2004, 2342–2343 RSC; (e) M. Liangwab and J. Chen, Chem. Soc. Rev., 2013, 42, 3453–3488 RSC; (f) A. Mishra, M. K. R. Fischer and P. Bauerle, Angew. Chem., Int. Ed., 2009, 48, 2474–2499 CrossRef CAS PubMed; (g) Y. Li, T. Liu, H. Liu, M. Z. Tian and Y. Li, Acc. Chem. Res., 2014, 47, 1186–1198 CrossRef CAS PubMed.
  2. (a) P. Sonar, S. P. Singh, Y. Li, M. S. Soh and A. Dodabalapur, Adv. Mater., 2010, 22, 5409–5413 CrossRef CAS PubMed; (b) W. S. Zhang, D. Wang, H. Cao and H. Yang, Tetrahedron, 2014, 70, 573–577 CrossRef CAS PubMed; (c) J. L. Wang, Z. M. Tang, Q. Xiao, Y. Ma and J. Pei, Org. Lett., 2009, 11, 862–866 Search PubMed; (d) L. E. Poander, L. Pandey, S. Barlow, P. Tiwari, C. Risko, B. Kippelen, J. L. Bredas and S. R. Marder, J. Phys. Chem. C, 2011, 115, 23149–23163 CrossRef.
  3. (a) J.-L. Wang, Q. Xiao and J. Pei, Org. Lett., 2010, 12, 4164–4167 CrossRef CAS PubMed; (b) F. Bures, W. B. Schweizer, J. C. May, C. Boudon, J.-P. Gisselbrecht, M. Gross, I. Biaggio and F. Diederich, Chem.–Eur. J., 2007, 13, 5378–5387 CrossRef CAS PubMed; (c) J. L. Wang, Z. M. Tang, Q. Xiao, Y. Ma and J. Pei, Org. Lett., 2008, 10, 4271–4274 CrossRef CAS PubMed; (d) P. Kiprof, J. C. Carlson, D. R. Anderson and V. N. Nemykin, Dalton Trans., 2013, 42, 15120–15132 RSC; (e) I. Tamgho, A. Hasheminasab, J. T. Engle, V. N. Nemykin and C. J. Ziegler, J. Am. Chem. Soc., 2014, 136, 5623–5626 CrossRef CAS PubMed.
  4. (a) Z. M. Tang, T. Lei, K. L. Jiang, Y. L. Song and J. Pei, Chem.–Asian J., 2010, 5, 1911–1917 CrossRef CAS PubMed; (b) Y. Wu and W. Zhu, Chem. Soc. Rev., 2013, 42, 2039–2058 RSC; (c) Q. T. Zhang and J. M. Tour, J. Am. Chem. Soc., 1998, 120, 5355–5362 CrossRef CAS; (d) F. Gohier, P. Frère and J. Roncali, J. Org. Chem., 2013, 78, 1497–1503 CrossRef CAS PubMed; (e) P. Sonar, G.-M. Ng, G. T. T. Lin, A. Dodabalapur and Z.-K. Chen, J. Mater. Chem., 2010, 20, 3626–3636 RSC; (f) L.-Y. Lin, Y.-H. Chen, Z.-Y. Huang, H.-W. Lin, S.-H. Chou, F. Lin, C.-W. Chen, Y.-H. Liu and K.-T. Wong, J. Am. Chem. Soc., 2011, 133, 15822–15825 CrossRef CAS PubMed; (g) L. Dou, J. Gao, E. Richard, J. You, C.-C. Chen, K. C. Cha, Y. He, G. Li and Y. Yang, J. Am. Chem. Soc., 2012, 134, 10071–10079 CrossRef CAS PubMed.
  5. (a) S. Chen, Y. Li, W. Yang, N. Chen, H. Liu and Y. Li, J. Phys. Chem. C, 2010, 114, 15109–15115 CrossRef CAS; (b) S. Chen, Y. Li, C. Liu, W. Yang and Y. Li, Eur. J. Org. Chem., 2011, 6445–6451 CrossRef CAS.
  6. (a) W. Li, C. Du, F. Li, Y. Zhou, M. Fahlman, Z. Bo and F. Zhang, Chem. Mater., 2009, 21, 5327–5334 CrossRef CAS; (b) C. He, Q. He, Y. Yi, G. Wu, F. Bai, Z. Shuaia and Y. Li, J. Mater. Chem., 2008, 18, 4085–4090 RSC; (c) H. Shang, H. Fan, Y. Liu, W. Hu, Y. Li and X. Zhan, Adv. Mater., 2011, 23, 1554–1557 CrossRef CAS PubMed; (d) S. Ellinger, K. R. Graham, P. Shi, R. T. Farley, T. T. Steckler, R. N. Brookins, P. Taranekar, J. Mei, L. A. Padilha, T. R. Ensley, H. Hu, S. Webster, D. J. Hagan, E. W. V. Stryland, K. S. Schanze and J. R. Reynolds, Chem. Mater., 2011, 23, 3805–3817 CrossRef CAS.
  7. (a) R. Misra, R. Maragani, K. R. Patel and G. D. Sharma, RSC Adv., 2014, 4, 34904–34911 RSC; (b) R. Misra, P. Gautam, T. Jadhav and S. M. Mobin, J. Org. Chem., 2013, 78, 4940–4948 CrossRef CAS PubMed; (c) P. Gautam, R. Maragani and R. Misra, Tetrahedron Lett., 2014, 55, 6827–6830 CrossRef CAS PubMed; (d) R. Misra, R. Maragani, P. Gautam and S. M. Mobin, Tetrahedron Lett., 2014, 55, 7102–7105 CrossRef CAS PubMed.
  8. (a) R. Misra, P. Gautam and S. M. Mobin, J. Org. Chem., 2013, 78, 12440–12452 CrossRef CAS PubMed; (b) R. Misra and P. Gautam, Org. Biomol. Chem., 2014, 12, 5448–5457 RSC; (c) P. Gautam, R. Maragani, S. M. Mobin and R. Misra, RSC Adv., 2014, 4, 52526–52529 RSC.
  9. B. Wang, S. Tsang, W. Zhang, Y. Tao and M. S. Wong, Chem. Commun., 2011, 47, 9471–9473 RSC.
  10. R. Misra, P. Gautam, R. Sharma and S. M. Mobin, Tetrahedron Lett., 2013, 54, 381–383 CrossRef CAS PubMed.
  11. X. M. Ma, J. L. Hua, W. J. Wu and H. Tian, Tetrahedron, 2008, 64, 345–350 CrossRef CAS PubMed.
  12. H. Sun, X. Dong, S. Liu, Q. Zhao, X. Mou, H. Y. Yang and W. Huang, J. Phys. Chem. C, 2011, 115, 19947–19954 CAS.
  13. (a) M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery Jr, J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, N. J. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski and D. J. Fox, Gaussian 09, revision A.02, Gaussian, Inc., Wallingford, CT, 2009 Search PubMed; (b) C. Lee, W. Yang and R. G. Parr, Phys. Rev. B: Condens. Matter Mater. Phys., 1988, 37, 785–789 CrossRef CAS; (c) A. D. Becke, J. Chem. Phys., 1993, 98, 1372–1377 CrossRef CAS PubMed.
  14. (a) H. Zhang, X. Wan, X. Xue, Y. Li, A. Yu and Y. Chen, Eur. J. Org. Chem., 2010, 1681–1687 CrossRef CAS; (b) G. Qian, B. Dai, M. Luo, D. Yu, J. Zhan, Z. Zhang, D. Ma and Z. Y. Wang, Chem. Mater., 2008, 20, 6208–6216 CrossRef CAS.
  15. (a) S. Kato, T. Matsumoto, M. Shigeiwa, H. Gorohmaru, S. Maeda, T. Ishi-I and S. Mataka, Chem.–Eur. J., 2006, 12, 2303–2317 CrossRef CAS PubMed; (b) B. Wang, H. Pan, J. Jia, Y. Q. Ge, W. Q. Cai, J. W. Wang and C. H. Zhao, Tetrahedron, 2014, 70, 5488–5493 CrossRef CAS PubMed.
  16. (a) M. Watanabe, K. Goto, M. Shibahara and T. Shinmyozu, J. Org. Chem., 2010, 75, 6104–6114 CrossRef CAS PubMed; (b) E. Xu, H. Zhong, H. Lai, D. Zeng, J. Zhang, W. Zhu and Q. Fang, Macromol. Chem. Phys., 2010, 211, 651–656 CrossRef CAS; (c) M. Watanabe, K. Goto, M. Fujitsuka, S. Tojo, T. Majima and T. Shinmyozu, Bull. Chem. Soc. Jpn., 2010, 83, 1155–1161 CrossRef CAS.
  17. (a) B. Dhokale, P. Gautam and R. Misra, Tetrahedron Lett., 2012, 53, 2352–2354 CrossRef CAS PubMed; (b) P. Gautam, B. Dhokale, S. M. Mobin and R. Misra, RSC Adv., 2012, 2, 12105–12107 RSC.
  18. (a) M.-H. Tsai, H.-W. Lin, H.-C. Su, T.-H. Ke, C.-C. Wu, F.-C. Fang, Y.-L. Liao, K.-T. Wong and C.-I. Wu, Adv. Mater., 2006, 18, 1216 CrossRef CAS; (b) X. Tang, W. Liu, J. Wu, C.-S. Lee, J. You and P. Wang, J. Org. Chem., 2010, 75, 7273–7278 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: Characterization data for all the new compounds. Copies of 1H, 13C NMR, and HRMS spectra, electrochemical and DFT calculation data of new compounds. See DOI: 10.1039/c4ra15424j

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.